Word from the Course Directors 2025:

Musculoskeletal pain continues to be a leading cause of disability among aging patients in the world.  Many patients live with chronic pain and others rely on drugs, physical therapy, invasive surgeries, and more to get relief.  The increasing preference among patients for minimally invasive procedures coupled with the effectiveness of these techniques is leading to a surge in interest in embolotherapy as a safe and minimally invasive procedure to treat MSK pain.

The GEST community of interventional radiologists and interventional oncologists has expressed avid interest in this discipline through multiple venues.  Our virtual Summit on MSK had a record number of registrants and the attendance at the first two editions of our educational meeting dedicated to MSK in Paris has grown year over year.  The intrigue and interest in this topic is a multidisciplinary one, attracting interest from rheumatologists, orthopedic surgeons, and others.

Based on the feedback from our community, we are excited to come back to Paris for a third year in a row to deliver another outstanding training program on this topic.  You asked us to continue to deliver all the things you loved about these meetings, and we will.  But we are also stacking the program with more of the things you asked for – live and recorded cases, more small group interaction with speakers, interdisciplinary talks, patient testimonials, and more.

Our ultimate goal is to have you say to us that you don’t feel like newbies on this topic.  In fact, success to us would be when you come back and share your experiences on how you are growing your practice in this area and making a difference for patients, so they don’t have to live with pain.

See you in Paris on January 18^th and 19^th 2025!

The Course Directors